Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
NCT04937660
·
clinicaltrials.gov ↗
COMPLETED
Status
185
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Breast Cancer
Sponsor
Pfizer